FUTURE 3 Study Extension
NCT01338415
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
58
Enrollment
INDUSTRY
Sponsor class
Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG:
Bosentan
Sponsor
Actelion